Shelley C Heaton

Shelley C Heaton, Ph.D.

Clinical Associate Professor & Director, UFHealth Psychology Specialties

Department: Department of Clinical and Health Psychology
Business Phone: (352) 265-0294
Business Email: sheaton@ufl.edu

About Shelley C Heaton

Dr. Shelley Heaton is Director of UFHealth Psychology Specialties and Clinical Associate Professor in the Department of Clinical & Health Psychology at the University of Florida (UF), where she mentors doctoral students, teaches, engages in collaborate research, and maintains a busy clinical practice and provides specialized training in pediatric neuropsychology. Dr. Heaton is active in professional service, both nationally and locally. She has been a Consulting Editor to the Child Neuropsychology journal since 2006, and has served Division 40 of the American Psychological Association (APA) in several capacities over the past 10 years. Dr. Heaton has also provided valuable service to the UF community through her work with the Disability Resource Center and the McNair Scholarship Program. Dr. Heaton also directs a Pediatric Traumatic Brain Injury (TBI) Program at the University of Florida, which provides clinical services and conducts scientific research with youth recovering from TBI. She received her Ph.D. in Clinical Psychology in 2001 from the University of California San Diego after completing an internship in neuropsychology at the University of Florida. Her areas of clinical and scientific interest include: Pediatric Neuropsychology, Traumatic Brain Injury (TBI) Across the Lifespan, Attention Deficit/Hyperactivity Disorder (ADHD), Pediatric Brain Tumors and Cancer, Attention and Memory Impairments in Childhood Conditions, Measurement Issues Pertaining to Cognition, and Forensic Pediatric Neuropsychology.

Accomplishments

Superior Accomplishment Award
2020 · UF College of Public Health & Health Professions

Clinical Profile

Specialties
  • Psychology
Subspecialties
  • Clinical Child / Pediatric Psychology
Areas of Interest
  • Attention deficit hyperactivity disorder
  • Brain tumor – children
  • Depression – overview
  • Duchenne muscular dystrophy
  • Dystonia
  • Epilepsy – overview
  • Seizures
  • Sickle cell disease
  • Traumatic Brain Injury

Research Profile

Dr. Heaton is an avid collaborator on a variety of internally and externally funded research studies, providing expertise on neuropsychological measurement across the lifespan. Her research endeavors have been quite diverse (ranging from her early work studying the neuropsychology of adult schizophrenia to her ongoing independent research examining cognitive and behavioral outcomes after pediatric traumatic brain injury). During her time at UF, Dr. Heaton’s research has primarily focused on novel ways to measure cognitive functioning (“outcome”) after neurological insult, studying short and long-term outcomes after traumatic brain injury across the lifespan, and examining the relationship between attention, executive and memory functions in pediatric conditions. Aside from her independent research and collaborations with many professions within UF Health Shands Hospital and the UF Health Science Center, Dr. Heaton also has provided research mentorship to more than three dozen UF undergraduate students conducting senior honor’s theses and doctoral students within the Department of Clinical & Health Psychology.

Open Researcher and Contributor ID (ORCID)

0000-0001-5860-522X

Publications

2021
Making a Difference: Affective Distress Explains Discrepancy Between Objective and Subjective Cognitive Functioning After Mild Traumatic Brain Injury.
The Journal of head trauma rehabilitation. 36(3):186-195 [DOI] 10.1097/HTR.0000000000000618. [PMID] 32898033.
2021
New cut-score to improve performance of the Memory Validity Profile (MVP) in heterogenous clinical populations.
Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence. 1-12 [DOI] 10.1080/09297049.2021.1876013. [PMID] 33499739.
2019
Behavioral Therapy for Acute Post-Surgical Phantom Limb Pain in a Young Adult With Osteosarcoma.
Pain practice : the official journal of World Institute of Pain. 19(5):571-572 [DOI] 10.1111/papr.12768. [PMID] 30681260.
2019
Predicting long-term cognitive and neuropathological consequences of moderate to severe traumatic brain injury: Review and theoretical framework.
Journal of clinical and experimental neuropsychology. 41(8):775-785 [DOI] 10.1080/13803395.2019.1620695. [PMID] 31156042.
2018
Temporal Profile of Microtubule-Associated Protein 2: A Novel Indicator of Diffuse Brain Injury Severity and Early Mortality after Brain Trauma.
Journal of neurotrauma. 35(1):32-40 [DOI] 10.1089/neu.2017.4994. [PMID] 28895474.
2018
The Relationship Between Sleep and Cognition in Children Referred for Neuropsychological Evaluation: A Latent Modeling Approach.
Children (Basel, Switzerland). 5(3) [DOI] 10.3390/children5030033. [PMID] 29495597.
2018
The Role of Executive Functioning and Academic Achievement in the Academic Self-Concept of Children and Adolescents Referred for Neuropsychological Assessment.
Children (Basel, Switzerland). 5(7) [DOI] 10.3390/children5070083. [PMID] 29933565.
2016
Factor structure and item level psychometrics of the Social Problem Solving Inventory-Revised: Short Form in traumatic brain injury.
Neuropsychological rehabilitation. 26(3):446-63 [DOI] 10.1080/09602011.2015.1044458. [PMID] 26052731.
2015
Biomarkers improve clinical outcome predictors of mortality following non-penetrating severe traumatic brain injury.
Neurocritical care. 22(1):52-64 [DOI] 10.1007/s12028-014-0028-2. [PMID] 25052159.
2014
Conventional Vs Quantitative Approach in Assessing Post-Traumatic Ventriculomegaly and Its Relation To 6-Month Outcomes in Severe Traumatic Brain Injury
Journal of Neurotrauma. 31(5):A66-A67
2014
Human traumatic brain injury induces autoantibody response against glial fibrillary acidic protein and its breakdown products.
PloS one. 9(3) [DOI] 10.1371/journal.pone.0092698. [PMID] 24667434.
2014
Lateral Ventricle Volume Asymmetry Predicts Midline Shift and 6-Month Outcome in Severe Traumatic Brain Injury
Journal of Neurotrauma. 31(5)
2014
Microtubule-Associated Protein 2 (Map2) Csf Biokinetic Characteristics Are Associated With Poor Outcomes in Severe Tbi Patients
Journal of Neurotrauma. 31(12)
2014
Psychology’s Role in Patient-Centered, Evidence-Based, Interdisciplinary Treatment: a Case Study of Phantom Limb Pain
Psycho-Oncology. 23(1, SI)
2014
UCH-L1 and GFAP Serum Levels in Neonates with Hypoxic-Ischemic Encephalopathy: A Single Center Pilot Study.
Frontiers in neurology. 5 [DOI] 10.3389/fneur.2014.00273. [PMID] 25566179.
2014
Y Lateral Ventricle Volume Asymmetry Is Related To Spectrin Breakdown
Journal of Neurotrauma. 31(5):A67-A68
2013
Cognitive predictors of verbal memory in a mixed clinical pediatric sample.
Behavioral sciences (Basel, Switzerland). 3(3):522-35 [DOI] 10.3390/bs3030522. [PMID] 25379253.
2012
Assessing a Necrosis and Apoptosis Index Using Csf Alpha Ii-Spectrin Breakdown Product Levels in Severe Tbi
Journal of Neurotrauma. 29:A93-A94
2012
Early Csf Levels of Uch-L1 Are Associated With Measures of Injury Severity in Patients With Severe Tbi
Journal of Neurotrauma. 29
2012
Early Csf Levels of Uch-L1 Are Associated With Measures of Injury Severity in Patients With Severe Tbi
Journal of Neurotrauma. 29
2012
Exposure Characteristics of Uch-L1 in Csf Are Associated With 6-Month Outcome in Severe Tbi
Journal of Neurotrauma. 29
2012
Marshall Classification Versus the Rotterdam Score in Predicting 6-Month Mortality in Severe Tbi
Journal of Neurotrauma. 29:A191-A192
2012
Parent-child interaction therapy as a family-oriented approach to behavioral management following pediatric traumatic brain injury: a case report.
Journal of pediatric psychology. 37(3):251-61 [DOI] 10.1093/jpepsy/jsr086. [PMID] 22004884.
2012
Predicting Mortality in Severe Tbi Using the Impact Score and Early Csf Map-2 Levels
Journal of Neurotrauma. 29
2012
Predicting Poor 6-Month Outcome in Severe Tbi Using the Impact Score and Early Csf Biomarkers
Journal of Neurotrauma. 29
2012
The item level psychometrics of the behaviour rating inventory of executive function-adult (BRIEF-A) in a TBI sample.
Brain injury. 26(13-14):1646-57 [DOI] 10.3109/02699052.2012.700087. [PMID] 22876936.
2012
Uch-L1 and Map-2 Biomarkers Improve 6-Month Functional Outcome Prediction in Severe Traumatic Brain Injury
Journal of Neurotrauma. 29:A42-A43
2011
Conceptualizing functional cognition in traumatic brain injury rehabilitation.
Brain injury. 25(4):348-64 [DOI] 10.3109/02699052.2011.556105. [PMID] 21323413.
2010
Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury.
Critical care medicine. 38(1):138-44 [DOI] 10.1097/CCM.0b013e3181b788ab. [PMID] 19726976.
2009
alphaII-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury.
Journal of neurotrauma. 26(4):471-9 [DOI] 10.1089/neu.2008.0657. [PMID] 19206997.
2009
Development of An Item Bank for a Computer Adaptive Measure of Functional Cognition for Stroke
Value in Health. 12 [DOI] 10.1016/S1098-3015(10)73143-0.
2009
The role of multidimensional attentional abilities in academic skills of children with ADHD.
Journal of learning disabilities. 42(3):240-9 [DOI] 10.1177/0022219408331042. [PMID] 19264927.
2008
Conceptualizing functional cognition in stroke.
Neurorehabilitation and neural repair. 22(2):122-35 [PMID] 17761809.
View on: PubMed
2008
Levels of Uch-L1 in Human Csf and Outcome Following Severe Traumatic Brain Injury
Journal of Neurotrauma. 25
2008
Using Fda Pro Guidelines To Develop a Computerized Adaptive Outcome Measure of Functional Cognition for Stroke
. 39:702-703
2007
Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury.
Journal of neurotrauma. 24(2):354-66 [PMID] 17375999.
View on: PubMed
2001
The Test of Everyday Attention for Children (TEA-Ch): patterns of performance in children with ADHD and clinical controls.
Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence. 7(4):251-64 [PMID] 16210214.
View on: PubMed
1999
Schizoaffective disorder: a form of schizophrenia or affective disorder?
The Journal of clinical psychiatry. 60(12):874-82 [PMID] 10665641.
View on: PubMed
1997
Validity of specific subscales of the positive and negative symptom scales in older schizophrenia outpatients.
Schizophrenia research. 27(2-3):219-26 [PMID] 9416651.
View on: PubMed
1996
Clinical and neuropsychological comparison of psychotic depression with nonpsychotic depression and schizophrenia.
The American journal of psychiatry. 153(4):490-6 [PMID] 8599396.
View on: PubMed

Grants

Jul 2014 – Jun 2017
Clinical utility of blood based biomarkers for management of neonatal HIE
Role: Project Manager
Funding: AMER HEART ASSOCIATION

Education

Pediatric Neuropsychology Fellowship
2003 · University of Florida (UF)
Neuropsychology Internship
2001 · University of Florida (UF)
Ph.D.
2001 · University of California, San Diego (UCSD)

Teaching Profile

Courses Taught
2009-2011,2013-2021
CLP6948 Advanced Practicum in Clinical Child Psychology
2016-2021
CLP7979 Advanced Research
2011,2015-2021
CLP6945 Advanced Practicum in Neuropsychology
2015,2019-2021
CLP6971 Research for Master’s Thesis
2009-2011,2014-2018,2016-2021
CLP7980 Research for Doctoral Dissertation
2011,2013-2021
CLP3911 Introduction to Clinical Research
2009,2013-2016,2016-2020,2018-2020,2020
CLP7934 Special Topics In Clinical Psychology
2008-2010,2013-2021,2019-2021
HSC4970 Public Health and Health Professions Senior Honors Thesis
2011,2014-2019,2019
CLP6905 Individual Work
2013-2016,2018
CLP6947 Practicum in Intervention
2009,2011-2017,2017
CLP7427C Neuropsychological Assessment of Children
2015-2016
CLP6943 Core Practicum in Clinical Psychology
2010-2016
CLP6430 Clinical Psychological Assessment
2010,2013
CLP6940 Supervised Teaching
2009
IDS4906 Interdisciplinary Thesis Research
2008-2009
CLP6307 Human Higher Cortical Functioning

Contact Details

Phones:
Business:
(352) 265-0294
Emails:
Business:
sheaton@ufl.edu
Practice Manager: